Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin added to standard Helicobacter pylori eradication therapy
IRCT20190823044589N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of atorvastatin in Helicobacter pylori infection (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Eradication of Helicobacter pylori. Started Apr 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20190823044589N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190823044589N1.